The general baseline data included age of NSCLC patients, CRF score, patient quality of life score after chemotherapy, KPS efficacy status score, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, creatinine (Scr) level, blood urea nitrogen (BUN) level, gender, marriage, education, occupation, disease course, cancer stage, and TCM syndrome type (P > 0.05). This evidence concerns the gene GPT and cancer.